A Clinical Comparison of Two Soft Contact Lenses

Sponsor
Coopervision, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT05741450
Collaborator
(none)
45
1
2
20
68.5

Study Details

Study Description

Brief Summary

The study objective was to gather short-term clinical performance data for two soft contact lenses.

Condition or Disease Intervention/Treatment Phase
  • Device: Monthly Replacement Spherical Silicone Hydrogel Contact Lens 1
  • Device: Daily Disposable Spherical Silicone Hydrogel Contact Lens 2
N/A

Detailed Description

The aim of this study was to evaluate the short-term clinical performance of a monthly sphere contact lens when compared to a daily disposable contact lens after 15 minutes of daily wear each.

Study Design

Study Type:
Interventional
Actual Enrollment :
45 participants
Allocation:
Non-Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Clinical Comparison of Two Soft Contact Lenses
Actual Study Start Date :
Nov 15, 2022
Actual Primary Completion Date :
Dec 5, 2022
Actual Study Completion Date :
Dec 5, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Monthly Replacement Spherical Silicone Hydrogel Contact Lens 1

Subjects will wear Monthly Replacement Silicone Hydrogel Contact Lens 1 for the first period of 15 minutes and Daily Disposable Spherical Silicone Hydrogel Contact Lens 2 for the second period of 15 minutes.

Device: Monthly Replacement Spherical Silicone Hydrogel Contact Lens 1
Monthly Replacement Spherical Silicone Hydrogel Contact Lens 1 - first period of 15 minutes

Experimental: Daily Disposable Silicone Hydrogel Contact Lens 2

Subjects will wear Daily Disposable Spherical Silicone Hydrogel Contact Lens 2 for the second period of 15 minutes.

Device: Daily Disposable Spherical Silicone Hydrogel Contact Lens 2
Daily Disposable Spherical Silicone Hydrogel Contact Lens 2 - second period of 15 minutes

Outcome Measures

Primary Outcome Measures

  1. Subjective Overall Score [15 minutes]

    Subjective overall score will be assessed using 0-100 visual analogue scale (0=Extremely poor. Cannot use lenses. and 100=Excellent. Highly impressed with these lenses overall.)

Secondary Outcome Measures

  1. Subjective Comfort [15 minutes]

    Subjective comfort score will be assessed using 0-100 visual analogue scale (0=Causes pain. Cannot be tolerated.; 100=Excellent. Cannot be felt.)

  2. Subjective Vision [15 minutes]

    Subjective vision score will be assessed using 0-100 visual analogue scale (0=Unacceptable. Lens cannot be worn.; 100=Excellent. Unaware of any visual loss.)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • They are of legal age (18) and capacity to volunteer.

  • They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.

  • They are willing and able to follow the protocol.

  • They currently wear soft contact lenses, or have done so within the past two years.

  • They are expected to be able to be fitted with the study lenses within the power range available.

Exclusion Criteria:
  • They have an ocular disorder which would normally contra-indicate contact lens wear.

  • They have a systemic disorder which would normally contra-indicate contact lens wear.

  • They are using any topical medication such as eye drops or ointment.

  • They are aphakic.

  • They have had corneal refractive surgery.

  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.

  • They are pregnant or lactating.

  • They have an eye or health condition including an immunosuppressive or infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or a history of anaphylaxis or severe allergic reaction.

  • They have taken part in any contact lens or care system clinical research within two weeks prior to starting this study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eurolens Research Manchester United Kingdom

Sponsors and Collaborators

  • Coopervision, Inc.

Investigators

  • Principal Investigator: Philip Morgan, PhD, MCOptom, Eurolens Research

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Coopervision, Inc.
ClinicalTrials.gov Identifier:
NCT05741450
Other Study ID Numbers:
  • C22-724 (EX-MKTG-138)
First Posted:
Feb 23, 2023
Last Update Posted:
Feb 23, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 23, 2023